While CeoTronics AG's (FRA:CEK) recent earnings report failed to ignite its stock price, a deeper look reveals a robust cash conversion story that may please long-term shareholders and point to healthier fundamentals than the headline profit figure suggests.
A Russian drone attack on a bus carrying Ukrainian miners home from work has left at least 12 dead and 8 wounded, officials say, in what is being condemned as a deliberate strike on civilians.
Igor Runets, founder and CEO of Russia's largest Bitcoin mining operator BitRiver, has been detained and placed under house arrest on charges of large-scale tax evasion. The case unfolds against a backdrop of Western sanctions and operational challenges for the once-dominant firm.
As Bitcoin grapples with volatility below $80,000, a packed U.S. economic calendar—featuring key jobs reports and MicroStrategy's Q4 earnings—is poised to dictate the cryptocurrency's near-term trajectory by shaping Federal Reserve policy expectations.
As gold and silver surged to record highs last month, Bitcoin's puzzling stagnation below $90,000 had traders searching for answers. A closer look at exchange order books reveals a deliberate play by large players to suppress price—a tactic that ultimately set the stage for last week's sharp decline.
As markets look ahead to 2026, a mix of established giants and emerging players in AI and digital advertising present compelling opportunities for investors seeking both growth and value.
The iconic pottery maker reports encouraging sales growth and a renewed focus on its craft heritage, aiming to return to profitability next year after a period of job cuts and industry-wide challenges.
The Swiss interdealer broker has delivered a stellar 213% total shareholder return since 2021, fueled by market confidence and robust dividends, despite recent slight pullback.
Snapchat has disabled hundreds of thousands of accounts belonging to users under 16 in Australia under new social media laws, but warns the legislation contains 'significant gaps' that may allow some minors to bypass protections.
As the pet care market expands, investors weigh the focused approach of Chewy against Walmart's diversified scale. While Chewy offers pure exposure, Walmart's broader ecosystem and advertising growth present a compelling alternative.
Lucky Strike Entertainment's stock has tumbled nearly 24% over the past year, raising critical questions about its true worth. We analyze whether the current price reflects underlying value or signals an overextended valuation.
Cardiac monitoring specialist iRhythm has finalized a significant corporate restructuring, creating a new parent company to serve as its publicly listed entity on Nasdaq. The move is seen as a strategic step to streamline governance and provide operational flexibility as the company expands its AI-driven health platform.
Shares of insulin pump maker Tandem Diabetes Care have plummeted over 80% in five years, trading near $20. A deep dive into valuation metrics suggests the stock may now be modestly undervalued, but significant risks and competitive pressures remain.
Shares of Advantest Corp. have surged nearly 200% in the past year, riding the AI and advanced chipmaking wave. As the stock trades near record highs, investors are grappling with a critical question: has the rally run too far, too fast?
After a staggering 75% surge over the past year, Tapestry's stock is under the microscope. While a discounted cash flow model suggests the shares are roughly fairly valued, its sky-high P/E ratio tells a more cautionary tale, raising questions about whether the market's optimism has gotten ahead of itself.
Tripadvisor and Best Western's new AI-driven travel platform for the 2026 FIFA World Cup showcases the company's potential in high-stakes tourism. Yet, for investors, the real test remains translating innovation into sustained growth and market-beating returns.
Amid a patchy eurozone recovery, investors are scanning the market's fringes for potential. We spotlight three small-cap stocks from Norway and Sweden, each navigating unique challenges while showing flashes of promise for the discerning, risk-tolerant investor.
Sanofi's experimental oral drug venglustat demonstrated significant neurological benefits for patients with Type 3 Gaucher disease in a late-stage trial, but failed to meet its primary endpoint in a separate study for Fabry disease, casting uncertainty on its regulatory path.
Shareholder analysis reveals a distinctive ownership structure at Swiss electrical engineering group Burkhalter Holding, where retail investors collectively hold the largest stake, while insiders retain significant control. This balance of power highlights both broad public interest and strong managerial alignment in the CHF1.5 billion company.
Cross-chain protocol CrossCurve has been exploited for an estimated $3 million, with a critical smart contract flaw allowing unauthorized fund withdrawals across multiple blockchains. The incident renews scrutiny on bridge security and user protections in decentralized finance.
